Trimethoprim-sulfamethoxazole treatment of Pneumocystis carinii pneumonitis. 1978

W E Larter, and T J John, and O F Sieber, and H Johnson, and J J Corrigan, and V A Fulginiti

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D011020 Pneumonia, Pneumocystis A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis. P carinii Pneumonia,P. carinii Pneumonia,P. jirovecii Pneumonia,PCP Pneumonia,Pneumocystis Pneumonia,Pneumocystosis,Pneumonia, Interstitial Plasma Cell,PCP Infection,Pneumocystis carinii Pneumonia,Pneumocystis jirovecii Pneumonia,Pneumonia, Pneumocystis carinii,Infection, PCP,P carinii Pneumonias,P. carinii Pneumonias,P. jirovecii Pneumonias,PCP Infections,PCP Pneumonias,Pneumocystis Pneumonias,Pneumocystoses,Pneumonia, P carinii,Pneumonia, P. carinii,Pneumonia, P. jirovecii,Pneumonia, PCP,Pneumonia, Pneumocystis jirovecii,Pneumonias, PCP
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D013420 Sulfamethoxazole A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208) Sulfamethylisoxazole,Gantanol,Sulfisomezole,Sulphamethoxazole
D014295 Trimethoprim A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported. Proloprim,Trimpex

Related Publications

W E Larter, and T J John, and O F Sieber, and H Johnson, and J J Corrigan, and V A Fulginiti
June 1975, Canadian Medical Association journal,
W E Larter, and T J John, and O F Sieber, and H Johnson, and J J Corrigan, and V A Fulginiti
January 1982, Reviews of infectious diseases,
W E Larter, and T J John, and O F Sieber, and H Johnson, and J J Corrigan, and V A Fulginiti
March 1974, Antimicrobial agents and chemotherapy,
W E Larter, and T J John, and O F Sieber, and H Johnson, and J J Corrigan, and V A Fulginiti
September 1976, The New England journal of medicine,
W E Larter, and T J John, and O F Sieber, and H Johnson, and J J Corrigan, and V A Fulginiti
June 1980, Annals of internal medicine,
W E Larter, and T J John, and O F Sieber, and H Johnson, and J J Corrigan, and V A Fulginiti
August 1991, AIDS (London, England),
W E Larter, and T J John, and O F Sieber, and H Johnson, and J J Corrigan, and V A Fulginiti
September 1991, DICP : the annals of pharmacotherapy,
W E Larter, and T J John, and O F Sieber, and H Johnson, and J J Corrigan, and V A Fulginiti
January 1987, Reviews of infectious diseases,
W E Larter, and T J John, and O F Sieber, and H Johnson, and J J Corrigan, and V A Fulginiti
March 1987, Annals of internal medicine,
W E Larter, and T J John, and O F Sieber, and H Johnson, and J J Corrigan, and V A Fulginiti
June 1981, The American journal of medicine,
Copied contents to your clipboard!